Last year we eagerly finalised the discussions on the continuation of NCOH after its first funding period, and the Strategic Research Agenda was formulated for 2022-2026. In addition to the four Strategic Research Themes, this period we will also be focussing on a few more overarching topics, such as pandemic preparedness.
Bert Poolman is a biochemistry professor at the University of Groningen and has been a member of the NCOH Executive Board since the summer of 2022. In the lab, he builds synthetic cells, and in his free time, he builds his holiday home in Italy. Poolman discusses his research, his role within NCOH and how Groningen researchers contribute.
Are you going on holiday soon? OHPact needs your help! Help us by working with us to map mosquitoes, ticks and the diseases they can transmit.
NCOH Student Travel Grant
The NCOH awards a number of travel grants to PhD students of NCOH Partners selected to present their abstract at an international One Health-related academic conference.
On 7 December 2022 Alexander Bakker successfully defended his thesis ‘Discovery of antibiotics and their targets in multidrug-resistant bacteria’ at Leiden University.
On 1 July 2022, the University of Groningen (UG) joined the Netherlands Center for One Health (NCOH) as a new Partner. Bert Poolman, professor Biochemistry at the Faculty of Science and Engineering: ‘Researchers from the University of Groningen contributing to NCOH cover a range of scientific disciplines, from biology, chemistry, pharmaceutical science to medicine’.
The gut microbiome forms a reservoir for opportunistic pathogens as well as for antimicrobial resistance genes. This finding is important because it offers a deeper insight in the dynamics and mechanism of antimicrobial resistance development. This project – supported by a grant from the Netherlands Centre for One Health – was performed by Paul Stege who defended his PhD thesis on November 9, 2022 at Utrecht University.
The National Reference Laboratory on Antimicrobial Resistance of Wageningen Bioveterinary Research (WBVR) in close cooperation with Wageningen Food Safety Research (WFSR) started whole genome sequencing (WGS) of all ESBL/AmpC-producing E. coli isolates to replace phenotypic antimicrobial susceptibility testing and additional PCR testing.